NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
ObjectivesPatients living with Parkinson's disease (PD) and related disorders are at increased risk of osteoporosis and fractures. However, bone health remains under-assessed in clinical practice. The aim of this study was to evaluate whether the FRAGILE tool that we previously developed improved osteoporosis screening and referral practices in a PD and related diseases clinic.MethodsWe performed an audit of 283 outpatient consultation letters evaluating the use of the FRAGILE tool for screening osteoporosis risk.ResultsFollowing implementation of the FRAGILE tool our referral rate for osteoporosis screening improved from 23% to 48% of at-risk patients. Specifically, marked improvements were seen in referrals for patients with osteopenia, falls and fractures, but factors such as osteoporosis-associated medications and medical comorbidities were still often overlooked.ConclusionsOsteoporosis screening referrals improved after introduction of the FRAGILE tool in clinical practice. Further efforts are required to address less overt risk factors.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.